Understanding how disordered proteins function in health and disease.

Disordered Proteins and Dynamic Interactions in Biology and Diseases.

NIH-funded research University of Massachusetts Amherst · NIH-11035105

This study is looking at special proteins that don't have a fixed shape but still play important roles in our bodies, to see how they might be linked to diseases like cancer and heart problems, with the hope of finding new ways to develop treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst NIH-funded
Lab location1 site (Hadley, United States)
Project IDNIH-11035105 on NIH RePORTER

What this research studies

This research investigates the role of intrinsically disordered proteins (IDPs) in various biological processes and diseases. It aims to understand how these proteins, which do not have a stable structure, can still perform essential functions in cells and how their dysfunction may lead to conditions like cancer and heart disease. The approach combines experimental measurements with advanced molecular simulations to provide a detailed understanding of these proteins in both healthy and diseased states. By exploring the dynamic interactions of IDPs, the research seeks to uncover potential therapeutic targets for drug development.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with cancers, neurodegenerative diseases, diabetes, or heart diseases.

Not a fit: Patients with conditions unrelated to protein dysfunction or those not diagnosed with the target diseases may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating diseases associated with disordered proteins, such as cancer and neurodegenerative disorders.

How similar studies have performed: Other research has shown promising results in understanding the role of disordered proteins in disease, indicating that this approach has potential for significant breakthroughs.

Where this research is happening

Hadley, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agentsanti-cancer drug
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.